Viatris Asks FDA Not To Approve Neffy Until Sponsor Conducts More PK/PD Studies

 
• By Brenda Sandburg
Anaphylaxis
Viatris says intranasal spray for treatment of anaphylaxis requires more PK/PD studies for approval • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers